{"protocolSection":{"identificationModule":{"nctId":"NCT06010641","orgStudyIdInfo":{"id":"Y (2023) 148"},"organization":{"fullName":"General Hospital of Shenyang Military Region","class":"OTHER"},"briefTitle":"Trendelenburg Position for Acute Anterior Circulation Ischemic Stroke With Large Artery Atherosclerosis Etiology (HOPES 3)","officialTitle":"Trendelenburg Position for Acute Anterior Circulation Ischemic Stroke With Large Artery Atherosclerosis Etiology (HOPES 3): a Prospective, Randomized, Open-label, Blinded-endpoint, Multi-center Trial"},"statusModule":{"statusVerifiedDate":"2024-01","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-01-10","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-10-30","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-10-30","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-08-20","studyFirstSubmitQcDate":"2023-08-20","studyFirstPostDateStruct":{"date":"2023-08-24","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-01-10","lastUpdatePostDateStruct":{"date":"2024-01-12","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Hui-Sheng Chen","investigatorTitle":"Director","investigatorAffiliation":"General Hospital of Shenyang Military Region"},"leadSponsor":{"name":"General Hospital of Shenyang Military Region","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The effect of head position as a nonpharmacological therapy on acute ischemic stroke (AIS) remains inconclusive. Recent HOPES2 (Head dOwn-Position for acutE moderate ischemic Stroke with large artery atherosclerosis) suggest the safety, feasibility, and potential benefit of the head-down position (HDP) in acute ischemic stroke. The current study aims to investigate the efficacy and safety of HDP in acute moderate ischemic stroke patients with large artery atherosclerosis."},"conditionsModule":{"conditions":["Stroke, Acute Ischemic"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"SINGLE","whoMasked":["OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":600,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Head-down position","type":"EXPERIMENTAL","description":"head-down position as an adjunct to guideline-based treatment","interventionNames":["Other: head-down position"]},{"label":"control","type":"OTHER","description":"guideline-based treatment","interventionNames":["Other: head-down position"]}],"interventions":[{"type":"OTHER","name":"head-down position","description":"-20° Trendelenburg as an adjunct to guideline-based treatment,","armGroupLabels":["Head-down position","control"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"proportion of favorable functional outcome","description":"favorable functional outcome defined as modified Rankin Score (mRS) 0-2. The minimum and maximum values of mRS are 0 and 6, respectively; higher score mean a worse outcome","timeFrame":"90±7 days"}],"secondaryOutcomes":[{"measure":"proportion of excellent functional outcome","description":"excellent functional outcome is defined as modified Rankin Score (mRS) 0-1. The minimum and maximum values of mRS are 0 and 6, respectively; higher score mean a worse outcome","timeFrame":"90±7 days"},{"measure":"ordinal distribution of modified Rankin Score (mRS)","description":"The minimum and maximum values of mRS are 0 and 6, respectively; higher score mean a worse outcome","timeFrame":"90±7 days"},{"measure":"early neurological deterioration (END)","description":"END is defined as more than 4-point increase in NIHSS within 48±12 hours, but was not a result of intracerebral hemorrhage","timeFrame":"48±12 hours"},{"measure":"early neurological improvement (ENI)","description":"ENI is defined as more than 4-point decrease in NIHSS within 48±12 hours","timeFrame":"48±12 hours"},{"measure":"Changes in National Institute of Health stroke scale (NIHSS)","description":"the minimum and maximum values of NIHSS are 0 and 42, respectively; higher NIHSS mean a worse outcome.","timeFrame":"48±12 hours"},{"measure":"Changes in National Institute of Health stroke scale (NIHSS)","description":"the minimum and maximum values of NIHSS are 0 and 42, respectively; higher NIHSS mean a worse outcome.","timeFrame":"10±2 days"},{"measure":"changes in infarct volume","timeFrame":"48±12 hours"},{"measure":"new stroke or other vascular event(s)","timeFrame":"90±7 days"},{"measure":"all-cause mortality","timeFrame":"90±7 days"}],"otherOutcomes":[{"measure":"changes in cortical oxygen saturation determined by near infrared spectroscopy","timeFrame":"24±8 hours"},{"measure":"changes in cortical oxygen saturation determined by near infrared spectroscopy","timeFrame":"48±12 hours"},{"measure":"changes in serum biomarkers","timeFrame":"48±12 hours"},{"measure":"changes in serum biomarkers","timeFrame":"10±2 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age ≥ 18 years old\n* Acute ischemic stroke confirmed by NCCT or MRI;\n* Moderate neurologic deficit (6≤ NIHSS ≤ 16) within 24 hours of onset, or progressing from mild (NIHSS ≤ 5) to moderate neurologic deficit (6≤ NIHSS ≤ 16) within 24 hours, requiring ≥ 4 point increase in NIHSS score although the onset time is beyond 24 hours;\n* Probable large artery atherosclerosis etiology based on the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria (responsible artery stenosis ≥ 50% or occlusion);\n* Anterior circulation stroke (internal carotid artery, M1 or M2 of middle cerebral artery);\n* First stroke onset or past stroke without obvious neurological deficit (mRS≤2);\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Pre-stroke disability (mRS≥3);\n* Patients with disturbance of consciousness;\n* Patients who plan to undergo or have completed thrombolysis or mechanical thrombectomy;\n* Hemorrhagic stroke or combined ischemic and hemorrhagic stroke;\n* Serious comorbidity, such as liver or kidney insufficiency, malignant tumor, etc;\n* Other stroke etiologies, such as cardiogenic embolism, arteritis, arterial dissection, moyamoya disease, etc;\n* Previous history of intracerebral hemorrhage within 1 year;\n* Any contraindication to head-down position (e.g. active vomiting, pneumonia, uncontrolled heart failure);\n* Planned carotid or intracranial revascularization within 3 months;\n* Severe uncontrolled hypertension (systolic blood pressure over 180mmHg or diastolic blood pressure over 100 mmHg);\n* Cardiac insufficiency (NYHA Class ≥II);\n* Pregnant or lactating women;\n* Comorbidity with other serious diseases;\n* Participating in other clinical trials within 3 months;\n* Patients not suitable for the study considered by researcher.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"Department of Neurology, General Hospital of Northern Theater Command","status":"RECRUITING","city":"Shenyang","zip":"110016","country":"China","contacts":[{"name":"Hui-Sheng Chen, Ph.D.","role":"CONTACT","phone":"+86 13352452086","email":"chszh@aliyun.com"}],"geoPoint":{"lat":41.79222,"lon":123.43278}}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000050197","term":"Atherosclerosis"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000001161","term":"Arteriosclerosis"},{"id":"D000001157","term":"Arterial Occlusive Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Stroke, Acute Ischemic","relevance":"HIGH"},{"id":"M25878","name":"Atherosclerosis","asFound":"Atherosclerosis","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M4159","name":"Arteriosclerosis","relevance":"LOW"},{"id":"M4155","name":"Arterial Occlusive Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}